Reimagining Europe’s health systems Summit 2026

Sandra Gallina is the Director-General of the European Commission’s DG SANTE. Her career at the Commission spans over three decades, during which she has held several senior roles, including Deputy Director-General for Trade and Director for Sustainable Development, Economic Partnership Agreements and Agri-food and Fisheries. She served as the EU’s chief negotiator for the EU-MERCOSUR Free Trade Agreement and was the lead negotiator on non-agricultural market access during the World Trade Organization’s Doha Round. Previously, Gallina worked in the Directorate-General for Taxation and Customs Union, focusing on international trade and regulatory policy. 

Stine Bosse is a Member of the European Parliament, currently serving as Vice-Chair of the Committee on Public Health. Prior to joining the Parliament, Bosse chaired the board of several major organisations, including PlanBørnefonden and TelePost Greenland, and held senior roles in the insurance sector. Known for a strong stance on corporate responsibility and governance, Bosse brings extensive experience from both civil society and business. Bosse is also recognised for advocacy in gender equality and children’s rights across Europe and beyond.

Alexander Horn is President and General Manager of the German hub at Eli Lilly & Company. He has more than 20 years of experience at Lilly, including 12 years in international marketing roles across the United States and Japan. Horn has held a range of leadership positions within the company, contributing to global commercial strategy and market development across key therapeutic areas. He has extensive experience in international pharmaceutical operations and cross-market business leadership.

Rob de Bie leads business development for Philips Europe’s patient monitoring portfolio, focusing on high-acuity care. He works with hospitals to improve access to and use of health data, enhancing patient safety and operational efficiency. Rob began his career as a registered intensive care nurse and has held roles bridging clinical practice and healthcare technology.

Marilena Vrana leads the European strategy of the Plasma Protein Therapeutics Association (PPTA), overseeing advocacy, communications and regulatory relations. Vrana directs the organisation’s EU public affairs work, including political outreach, stakeholder engagement and advocacy on key policy files. Vrana’s work centres on aligning industry perspectives with public policy priorities, helping to inform decision-making and strengthen dialogue between institutions, stakeholders and the communities they serve.

Kasper Ernest is Director General of GIRP, the European Healthcare Distribution Association. He previously led Affordable Medicines Europe, where he represented the interests of the off-patent medicines sector at EU level.

Ernest served as President of the European Medicines Verification Organisation (EMVO), overseeing the implementation of systems to combat falsified medicines. Prior to this he was Director of the EU and International department at the Confederation of Danish Enterprise.

Ernest has also sat on the boards of several European business organisations and Healthcare Denmark, and contributed to the Danish government’s Implementation Council, supporting the transposition of EU legislation.

Felicitas Riedl is the Director of the Innovation and Competitiveness Department at the EIB’s Projects Directorate. She oversees technical and economic due diligence of EIB’s projects in R&D-intensive sectors, including CRM, automotive, pharmaceutical and telecom industries, as well as education, health and digital infrastructures. In her department projects from the public and private sector are covered benefitting from the entire range of financial products offered by EIB. Before this role, she was the Head of the Life Science and Health Division. A key achievement during her tenure here was successfully leading the team through COVID-19, positioning EIB as a strong partner in the sector by establishing critical partnerships with organizations such as the World Health Organization, the Bill & Melinda Gates Foundation and the Welcome Trust.

Jorge leads the innovation agenda at Hospital Clínic Barcelona, a leading public tertiary hospital, and coordinates innovation activities across the Campus Clínic Barcelona ecosystem. This includes the hospital, the biomedical research institute IDIBAPS, the global health research centre ISGlobal and the non-profit foundation Mon Clínic. He also serves as a venture partner at Nina Capital, a venture capital firm investing in early-stage companies at the intersection of healthcare and technology, where he supports founders with strategic advice and connections.

Previously, Jorge was Director of Innovation at EIT Health, an independent body of the European Union that promotes innovation and entrepreneurship in healthcare and life sciences. Earlier in his career, he led digital health initiatives at Hospital Sant Joan de Déu Barcelona and directed the d·HEALTH Barcelona programme, inspired by Stanford Biodesign. Jorge is also a founding member of the European Society for Artificial Intelligence in Health and sits on its executive committee.

Elina Drakvik works on Sitra’s Health Data 2030 project and is part of the coordination team of Towards European Health Data Space Joint Action (TEHDAS). Her job involves promoting the secondary use of health data in Finland and Europe, and collaborating with international health ecosystems and organisations. Drakvik has over ten years of experience in European collaborations in the field of health research. She has worked as a project manager and work package leader in various EU-funded research projects in Finland and Sweden, and she has experience in research funding and international co-operation. Drakvik’s professional interests include societal impact, participation and agency, and systemic change towards sustainable development, where health and well-being are understood in a broad sense. In addition to her position at Sitra, Elina is affiliated with the Faculty of Medicine at the University of Helsinki.